Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial

Authors:

Abstract
The WOEST-3 trial compares a 30-day dual antiplatelet therapy strategy with guideline-directed therapy in atrial fibrillation patients undergoing percutaneous coronary intervention.

This publication has 27 references indexed in Scilit: